Volume 11, Number 6—June 2005
Research
Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci in Rural Communities, Western United States
Table 1
Characterization | VRE |
MRSA |
||
---|---|---|---|---|
No. (N = 32) | % | No. (N = 724) | % | |
Healthcare-associated | 25 | 78 | 405 | 56 |
Community-associated | 7 | 22 | 319 | 44 |
without coexisting factors | 6 | 19 | 240 | 33 |
with coexisting factors | 1 | 3 | 79 | 11 |
Location of time of culture | ||||
Community | 9† | 28 | 391‡ | 54 |
Ward | 4 | 13 | 113 | 16 |
Intensive care unit | 0 | 0 | 24 | 3 |
Long-term care facility | 6 | 19 | 147 | 20 |
Transitional care unit | 12 | 38 | 19 | 3 |
Other hospital | 1 | 3 | 29 | 4 |
Clinical sources | ||||
Skin and soft tissue | 4 | 13 | 400 | 55 |
Urine | 15 | 47 | 104 | 14 |
Blood | 2 | 6 | 38 | 5 |
Sputum | 0 | 0 | 116 | 16 |
Other | 11 | 34 | 64 | 9 |
Unknown | 0 | 0 | 2 | 1 |
Coexisting factors | ||||
>65 years of age | 19 | 59 | 353 | 49 |
Diabetes mellitus | 4 | 13 | 142 | 20 |
Renal failure | 3 | 9 | 61 | 8 |
Prior antimicrobial therapy | 5 | 16 | 210 | 29 |
Immunosuppression | 6 | 19 | 77 | 11 |
Sex | ||||
Male | 14 | 44 | 382 | 53 |
Female | 18 | 56 | 342 | 47 |
*VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant Staphylococcus aureus.
†There were 2 VRE cases in which cultures were obtained in the community setting in patients with previous history of healthcare exposure (recent hospitalization, residence in long-term care facility).
‡There were 72 MRSA cases in which cultures were obtained in the community setting in patients with previous history of healthcare exposure. The location at the time of culture was unknown in one MRSA case.
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.